Effect of Comorbidities and Risk Factors on Outcomes and Ivabradine’s Effects in Patients With Chronic Systolic Heart Failure in the SHIFT Trial

2015 ◽  
Vol 21 (8) ◽  
pp. S46 ◽  
Author(s):  
Michael Böhm ◽  
Jeffrey S. Borer ◽  
Ian Ford ◽  
Michel Komajda ◽  
Michele Robertson ◽  
...  
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Systolic Heart Failure ◽  
Shift Trial ◽  
Chronic Systolic Heart Failure

Long‑term prognosis and risk factors for cardiac adverse events in patients with chronic systolic heart failure due to hypertension

2008 ◽  
Vol 118 (5) ◽  
pp. 280-288
Author(s):  
Bożena Szyguła‑Jurkiewicz ◽  
Aleksander Owczarek ◽  
Agata Duszańska ◽  
Jacek Sikora ◽  
Andrzej Lekston ◽  
...  
Keyword(s):  
Risk Factors ◽  
Heart Failure ◽  
Adverse Events ◽  
Systolic Heart Failure ◽  
Chronic Systolic Heart Failure ◽  
Long Term Prognosis ◽  
Cardiac Adverse Events

Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial

2015 ◽  
Vol 17 (12) ◽  
pp. 1294-1301 ◽  
Author(s):  
Michel Komajda ◽  
Luigi Tavazzi ◽  
Bernard G. Francq ◽  
Michael Böhm ◽  
Jeffrey S. Borer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systolic Heart Failure ◽  
Efficacy And Safety ◽  
Shift Trial ◽  
Chronic Systolic Heart Failure
Sign in / Sign up

Export Citation Format

Share Document